Marie Øbro Fosbøl

Medicine & Life Sciences

1. Radium-223 100%
2. Castration 89%
3. Urokinase Plasminogen Activator Receptors 84%
4. Prostatic Neoplasms 79%
5. Positron Emission Tomography Computed Tomography 49%
6. Fluorodeoxyglucose F18 42%
7. Bone and Bones 31%
8. Olfactory Esthesioneuroblastoma 30%
9. Inappropriate ADH Syndrome 28%
10. Positron-Emission Tomography 28%
11. Multiparametric Magnetic Resonance Imaging 28%
12. Liquid Biopsy 28%
13. Pediatrics 25%
14. Bone Neoplasms 24%
15. Cystitis 24%
16. Rhabdomyosarcoma 23%
17. Neoplasm Metastasis 23%
18. Tomography 22%
19. Neoplasm Grading 22%
20. Time-to-Treatment 22%
21. Magnetic Resonance Imaging 22%
22. Survival 21%
23. Pulmonary Tuberculosis 21%
24. Head and Neck Neoplasms 20%
25. Therapeutics 20%
26. Tumor Burden 19%
27. Thorax 15%
28. Systematic Reviews 14%
29. Progression-Free Survival 14%
30. Databases 13%
31. Clinical Trials 13%
32. X-Rays 12%
33. Radionuclide Imaging 11%
34. Fluorine-18 10%
35. 1,4,7-triazacyclononane-N,N',N''-triacetic acid 9%
36. Child 8%
37. Tuberculosis 6%
38. Ligands 6%
39. Neuroendocrine Tumors 5%
40. Somatotypes 5%
41. Neoplasms 5%